We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

85 hedge funds and large institutions have $101M invested in Asensus Surgical, Inc. in 2017 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

256% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 9

80% more capital invested

Capital invested by funds: $56.4M → $101M (+$45M)

67% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 15

37% more funds holding

Funds holding: 6285 (+23)

22% more call options, than puts

Call options by funds: $2.97M | Put options by funds: $2.43M

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
85
Holders Change
+23
Holders Change %
+37.1%
% of All Funds
1.93%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
32
Increased
25
Reduced
15
Closed
9
Calls
$2.97M
Puts
$2.43M
Net Calls
+$543K
Net Calls Change
-$365K
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Aisling Capital
New York
$19.1M -$1.06M -34,344 -4%
SHI
2
SV Health Investors
Massachusetts
$14.6M
JP Morgan Chase
3
JP Morgan Chase
New York
$13.8M +$6.86M +222,800 +68%
Vanguard Group
4
Vanguard Group
Pennsylvania
$10.1M +$4.91M +159,571 +66%
RG
5
Redmile Group
California
$9.68M +$11.9M +385,984 New
MCM
6
Masters Capital Management
Georgia
$7.48M -$296K -9,615 -3%
SG
7
StepStone Group
California
$5.85M
BlackRock
8
BlackRock
New York
$3.4M +$2.55M +82,779 +157%
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$2M +$1.11M +36,143 +83%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$1.84M +$1.71M +55,519 +309%
IBT
11
International Biotechnology Trust
United Kingdom
$1.71M
SM
12
Sabby Management
Florida
$1.37M +$1.68M +54,469 New
Geode Capital Management
13
Geode Capital Management
Massachusetts
$1.29M
GCP
14
GSA Capital Partners
United Kingdom
$1.07M +$1.32M +42,826 New
EGI
15
EAM Global Investors
California
$706K +$866K +28,153 New
PVAM
16
Pacific View Asset Management
California
$667K +$818K +26,586 New
EI
17
EAM Investors
California
$627K +$769K +24,984 New
Northern Trust
18
Northern Trust
Illinois
$450K +$49.2K +1,598 +10%
Millennium Management
19
Millennium Management
New York
$412K -$1.55M -50,394 -75%
Morgan Stanley
20
Morgan Stanley
New York
$327K +$314K +10,202 +363%
LPL Financial
21
LPL Financial
California
$327K +$401K +13,044 New
California Public Employees Retirement System
22
California Public Employees Retirement System
California
$312K
AG
23
Advisor Group
Arizona
$265K +$32.3K +1,050 +11%
AWM
24
AE Wealth Management
Kansas
$251K +$57.4K +1,865 +23%
IHM
25
Iguana Healthcare Management
New York
$241K +$296K +9,615 New

ASXC Hedge Fund Activity: Q4 2017 in Review

85 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q4 2017, worth a combined $101M — up 80% from $56.4M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new ASXC positions and 9 closed out — a net gain of 23 holders — while 25 added to existing stakes and 15 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $11.9M. The largest seller was Credit Suisse, exiting entirely with an estimated $1.72M sold.

  • 85 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q4 2017, up from 62 in Q3 2017.
  • Funds reported $101M of Asensus Surgical, Inc. stock for Q4 2017, up 80% quarter-over-quarter.
  • 32 funds opened new Asensus Surgical, Inc. positions in Q4 2017 and 9 closed out, a net change of +23 holders.
  • The largest Asensus Surgical, Inc. buyer in Q4 2017 was Redmile Group, an estimated $11.9M added.
  • The largest Asensus Surgical, Inc. seller in Q4 2017 was Credit Suisse, an estimated $1.72M sold.

Based on aggregated 13F filings for Q4 2017.